Black Raspberry and Reduced Monocyte Chemoattractant Protein-1 Level

Doses used in studies

mg/day: 900–1,800 (median 1,350, IQR 900–1,800) — 1 study

Time to effect

Median: 2.8 months · IQR 2.8 months–2.8 months · Range 2.8 months–2.8 months — Reported in 1 of 1 study

1 of 1 paper

Effect of Rubus Occidentalis Extract on Metabolic Parameters in Subjects with Prediabetes: A Proof-of-concept, Randomized, Double-blind, Placebo-controlled Clinical Trial.

2016-06-09
RCT · n = 17
Phytotherapy research : PTR 30(10)
- Jee Hyun An
- Dong-Lim Kim
- Tae-Bum Lee
- Kyeong Jin Kim
- Sun Hwa Kim
- Nam Hoon Kim
- Hee Young Kim
- Dong Seop Choi
- Sin Gon Kim

PubMed: 27279471
DOI: 10.1002/ptr.5664

4 Insights on

Reduced Monocyte Chemoattractant Protein-1 Level

High evidence
Clinical

Serum levels of monocyte chemoattractant protein-1 ... were significantly decreased by treatment in a dose-dependent manner (monocyte chemoattractant protein-1: -35.0 ± 21.2, +8.4 ± 18.1, and +24.2 ± 14.5 ... in the HRE, LRE, and placebo, respectively, p < 0.05).

Effect: Beneficial
Effect size: Small
Significant: Yes
Dose: 900 or 1800 mg per day